Latest Soft tissue sarcoma Stories
Benefit is not proven â€“ use can only be justified within controlled clinical trials at present.
CALGARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
CALGARY, Oct. 30 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.
Researchers at UCLA's Jonsson Comprehensive Cancer Center showed for the first time that the loss or decreased expression of the tumor suppressor gene PTEN plays a central role in the malignant transformation of benign nerve tumors called neurofibromas into a malignant and extremely deadly form of sarcoma.
Parkinson's Disease, Two Other Illnesses Recognized WASHINGTON, Oct. 13 /PRNewswire-USNewswire/ -- Relying on an independent study by the Institute of Medicine (IOM), Secretary of Veterans Affairs Eric K.
Berlin, Germany: Patients with soft-tissue sarcomas at high risk of spreading were 30% more likely to be alive and cancer free almost three years after starting treatment if their tumors were heated at the time they received chemotherapy, according to new research. The finding bolsters the case for intensifying exploration of the strategy in other types of cancer.
A new analysis suggests patients and physicians should rethink the pros and cons of limb-sparing surgery versus amputation for bone and soft tissue sarcomas of the lower limb.
Limb-sparing surgery, which has been taking the place of amputation for bone and soft tissue sarcomas of the lower limb in recent years, may not provide much or even any additional benefit to patients according to a new review. The analysis, published in the September 15, 2009 issue of Cancer
SAN MARINO, Calif., June 22 /PRNewswire/ -- Epeius Biotechnologies (www.epeiusbiotech.com) stuns the medical and scientific communities with a dramatic demonstration of single-agent efficacy with its lead product, Rexin-G, for metastatic cancer.
Rhabdomyosarcoma (RMS) is an aggressive muscle cancer that mostly affects children.
- In medieval musical notation, a sign or neume denoting a shake or trill.